TY - JOUR AU - Takahashi, S. PY - 2011 DA - 2011// TI - Current findings for recurring mutations in acute myeloid leukemia JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-36 DO - 10.1186/1756-8722-4-36 ID - Takahashi2011 ER - TY - JOUR AU - Takahashi, S. PY - 2011 DA - 2011// TI - Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-13 DO - 10.1186/1756-8722-4-13 ID - Takahashi2011 ER - TY - JOUR AU - Zhu, X. AU - Ma, Y. AU - Liu, D. PY - 2010 DA - 2010// TI - Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights JO - J Hematol Oncol VL - 3 UR - https://doi.org/10.1186/1756-8722-3-17 DO - 10.1186/1756-8722-3-17 ID - Zhu2010 ER - TY - JOUR AU - Rivera, E. PY - 2003 DA - 2003// TI - Liposomal anthracyclines in metastatic breast cancer: clinical update JO - Oncologist VL - 8 UR - https://doi.org/10.1634/theoncologist.8-suppl_2-3 DO - 10.1634/theoncologist.8-suppl_2-3 ID - Rivera2003 ER - TY - JOUR AU - Barrett-Lee, P. J. AU - Dixon, J. M. AU - Farrell, C. AU - Jones, A. AU - Leonard, R. AU - Murray, N. AU - Palmieri, C. AU - Plummer, C. J. AU - Stanley, A. AU - Verrill, M. W. PY - 2009 DA - 2009// TI - Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk JO - Annals of oncology: official journal of the European Society for Medical Oncology/ESMO VL - 20 UR - https://doi.org/10.1093/annonc/mdn728 DO - 10.1093/annonc/mdn728 ID - Barrett-Lee2009 ER - TY - JOUR AU - Zhang, S. H. AU - Wang, W. Q. AU - Wang, J. L. PY - 2009 DA - 2009// TI - Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo JO - Acta Pharmacol Sin VL - 30 UR - https://doi.org/10.1038/aps.2009.144 DO - 10.1038/aps.2009.144 ID - Zhang2009 ER - TY - JOUR AU - O’Shaughnessy, J. PY - 2003 DA - 2003// TI - Liposomal anthracyclines for breast cancer: overview JO - Oncologist VL - 8 UR - https://doi.org/10.1634/theoncologist.8-suppl_2-1 DO - 10.1634/theoncologist.8-suppl_2-1 ID - O’Shaughnessy2003 ER - TY - JOUR AU - Harris, L. AU - Batist, G. AU - Belt, R. AU - Rovira, D. AU - Navari, R. AU - Azarnia, N. AU - Welles, L. AU - Winer, E. AU - Group, T. D. S. PY - 2002 DA - 2002// TI - Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10201 DO - 10.1002/cncr.10201 ID - Harris2002 ER - TY - STD TI - Lopez-Berestein G, IJ Fidler, CIBA-GEIGY Corporation: Liposomes in the therapy of infectious diseases and cancer: proceedings of a Ciba-Geigy-Squibb-UCLA colloquium, held at Lake Tahoe, California, February 16–20, 1988.New York: Liss E.R. Squibb & Sons., University of California Los Angeles; 1989 ID - ref9 ER - TY - JOUR AU - Al-Batran, S. E. AU - Meerpohl, H. G. AU - von Minckwitz, G. AU - Atmaca, A. AU - Kleeberg, U. AU - Harbeck, N. AU - Lerbs, W. AU - Hecker, D. AU - Sehouli, J. AU - Knuth, A. PY - 2006 DA - 2006// TI - Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer JO - Oncology VL - 70 UR - https://doi.org/10.1159/000093005 DO - 10.1159/000093005 ID - Al-Batran2006 ER - TY - JOUR AU - Safra, T. PY - 2003 DA - 2003// TI - Cardiac safety of liposomal anthracyclines JO - Oncologist VL - 8 UR - https://doi.org/10.1634/theoncologist.8-suppl_2-17 DO - 10.1634/theoncologist.8-suppl_2-17 ID - Safra2003 ER - TY - JOUR AU - Simunek, T. AU - Sterba, M. AU - Popelova, O. AU - Adamcova, M. AU - Hrdina, R. AU - Gersl, V. PY - 2009 DA - 2009// TI - Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron JO - Pharmacological reports: PR VL - 61 UR - https://doi.org/10.1016/S1734-1140(09)70018-0 DO - 10.1016/S1734-1140(09)70018-0 ID - Simunek2009 ER - TY - JOUR AU - Allen, T. M. AU - Mumbengegwi, D. R. AU - Charrois, G. J. PY - 2005 DA - 2005// TI - Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates JO - Clinical cancer research: an official journal of the American Association for Cancer Research VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-2517 DO - 10.1158/1078-0432.CCR-04-2517 ID - Allen2005 ER - TY - JOUR AU - O’Brien, M. E. AU - Wigler, N. AU - Inbar, M. AU - Rosso, R. AU - Grischke, E. AU - Santoro, A. AU - Catane, R. AU - Kieback, D. G. AU - Tomczak, P. AU - Ackland, S. P. PY - 2004 DA - 2004// TI - Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer JO - Annals of oncology: official journal of the European Society for Medical Oncology/ESMO VL - 15 UR - https://doi.org/10.1093/annonc/mdh097 DO - 10.1093/annonc/mdh097 ID - O’Brien2004 ER - TY - JOUR AU - Balazsovits, J. A. AU - Mayer, L. D. AU - Bally, M. B. AU - Cullis, P. R. AU - McDonell, M. AU - Ginsberg, R. S. AU - Falk, R. E. PY - 1989 DA - 1989// TI - Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin JO - Cancer Chemother Pharmacol VL - 23 UR - https://doi.org/10.1007/BF00273522 DO - 10.1007/BF00273522 ID - Balazsovits1989 ER - TY - JOUR AU - Batist, G. AU - Ramakrishnan, G. AU - Rao, C. S. AU - Chandrasekharan, A. AU - Gutheil, J. AU - Guthrie, T. AU - Shah, P. AU - Khojasteh, A. AU - Nair, M. K. AU - Hoelzer, K. PY - 2001 DA - 2001// TI - Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer JO - Journal of clinical oncology: official journal of the American Society of Clinical Oncology VL - 19 ID - Batist2001 ER - TY - JOUR AU - Kanter, P. M. AU - Bullard, G. A. AU - Ginsberg, R. A. AU - Pilkiewicz, F. G. AU - Mayer, L. D. AU - Cullis, P. R. AU - Pavelic, Z. P. PY - 1993 DA - 1993// TI - Comparison of the cardiotoxic effects of liposomal doxorubicin (TLC D-99) versus free doxorubicin in beagle dogs JO - In Vivo VL - 7 ID - Kanter1993 ER - TY - JOUR AU - Kanter, P. M. AU - Bullard, G. A. AU - Pilkiewicz, F. G. AU - Mayer, L. D. AU - Cullis, P. R. AU - Pavelic, Z. P. PY - 1993 DA - 1993// TI - Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs JO - In Vivo VL - 7 ID - Kanter1993 ER - TY - JOUR AU - Mayer, L. D. AU - Bally, M. B. AU - Cullis, P. R. AU - Wilson, S. L. AU - Emerman, J. T. PY - 1990 DA - 1990// TI - Comparison of free and liposome encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor JO - Cancer Lett VL - 53 UR - https://doi.org/10.1016/0304-3835(90)90212-G DO - 10.1016/0304-3835(90)90212-G ID - Mayer1990 ER - TY - JOUR AU - Mayer, L. D. AU - Tai, L. C. AU - Bally, M. B. AU - Mitilenes, G. N. AU - Ginsberg, R. S. AU - Cullis, P. R. PY - 1990 DA - 1990// TI - Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients JO - Biochim Biophys Acta VL - 1025 UR - https://doi.org/10.1016/0005-2736(90)90091-2 DO - 10.1016/0005-2736(90)90091-2 ID - Mayer1990 ER - TY - JOUR AU - Franklin, H. R. AU - Simonetti, G. P. AU - Dubbelman, A. C. AU - ten Bokkel Huinink, W. W. AU - Taal, B. G. AU - Wigbout, G. AU - Mandjes, I. A. AU - Dalesio, O. B. AU - Aaronson, N. K. PY - 1994 DA - 1994// TI - Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting JO - Annals of oncology : official journal of the European Society for Medical Oncology/ESMO VL - 5 ID - Franklin1994 ER - TY - JOUR AU - Gill, P. S. AU - Wernz, J. AU - Scadden, D. T. AU - Cohen, P. AU - Mukwaya, G. M. AU - von Roenn, J. H. AU - Jacobs, M. AU - Kempin, S. AU - Silverberg, I. AU - Gonzales, G. PY - 1996 DA - 1996// TI - Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi’s sarcoma JO - Journal of clinical oncology: official journal of the American Society of Clinical Oncology VL - 14 ID - Gill1996 ER - TY - JOUR AU - Northfelt, D. W. AU - Dezube, B. J. AU - Thommes, J. A. AU - Miller, B. J. AU - Fischl, M. A. AU - Friedman-Kien, A. AU - Kaplan, L. D. AU - Du Mond, C. AU - Mamelok, R. D. AU - Henry, D. H. PY - 1998 DA - 1998// TI - Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi’s sarcoma: results of a randomized phase III clinical trial JO - Journal of clinical oncology: official journal of the American Society of Clinical Oncology VL - 16 ID - Northfelt1998 ER - TY - JOUR AU - Judson, I. AU - Radford, J. A. AU - Harris, M. AU - Blay, J. Y. AU - van Hoesel, Q. AU - le Cesne, A. AU - van Oosterom, A. T. AU - Clemons, M. J. AU - Kamby, C. AU - Hermans, C. PY - 2001 DA - 2001// TI - Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00050-8 DO - 10.1016/S0959-8049(01)00050-8 ID - Judson2001 ER - TY - JOUR AU - Dimopoulos, M. A. AU - Pouli, A. AU - Zervas, K. AU - Grigoraki, V. AU - Symeonidis, A. AU - Repoussis, P. AU - Mitsouli, C. AU - Papanastasiou, C. AU - Margaritis, D. AU - Tokmaktsis, A. PY - 2003 DA - 2003// TI - Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma JO - Annals of oncology: official journal of the European Society for Medical Oncology/ESMO VL - 14 UR - https://doi.org/10.1093/annonc/mdg287 DO - 10.1093/annonc/mdg287 ID - Dimopoulos2003 ER - TY - JOUR AU - Chan, S. AU - Davidson, N. AU - Juozaityte, E. AU - Erdkamp, F. AU - Pluzanska, A. AU - Azarnia, N. AU - Lee, L. W. PY - 2004 DA - 2004// TI - Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer JO - Annals of oncology: official journal of the European Society for Medical Oncology/ESMO VL - 15 UR - https://doi.org/10.1093/annonc/mdh393 DO - 10.1093/annonc/mdh393 ID - Chan2004 ER - TY - JOUR AU - Rifkin, R. M. AU - Gregory, S. A. AU - Mohrbacher, A. AU - Hussein, M. A. PY - 2006 DA - 2006// TI - Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial JO - Cancer VL - 106 UR - https://doi.org/10.1002/cncr.21662 DO - 10.1002/cncr.21662 ID - Rifkin2006 ER - TY - JOUR AU - Von Hoff, D. D. AU - Layard, M. W. AU - Basa, P. AU - Davis, H. L. AU - Von Hoff, A. L. AU - Rozencweig, M. AU - Muggia, F. M. PY - 1979 DA - 1979// TI - Risk factors for doxorubicin-induced congestive heart failure JO - Ann Intern Med VL - 91 UR - https://doi.org/10.7326/0003-4819-91-5-710 DO - 10.7326/0003-4819-91-5-710 ID - Von Hoff1979 ER - TY - JOUR AU - Huedo-Medina, T. B. AU - Sanchez-Meca, J. AU - Marin-Martinez, F. AU - Botella, J. PY - 2006 DA - 2006// TI - Assessing heterogeneity in meta-analysis: Q statistic or I2 index? JO - Psychol Methods VL - 11 UR - https://doi.org/10.1037/1082-989X.11.2.193 DO - 10.1037/1082-989X.11.2.193 ID - Huedo-Medina2006 ER - TY - JOUR AU - Hu, J. AU - Zhao, G. AU - Wang, H. X. AU - Tang, L. AU - Xu, Y. C. AU - Ma, Y. AU - Zhang, F. C. PY - 2011 DA - 2011// TI - A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-11 DO - 10.1186/1756-8722-4-11 ID - Hu2011 ER - TY - JOUR AU - Wei, G. AU - Ni, W. AU - Chiao, J. W. AU - Cai, Z. AU - Huang, H. AU - Liu, D. PY - 2011 DA - 2011// TI - A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome JO - J Hematol Oncol VL - 4 UR - https://doi.org/10.1186/1756-8722-4-46 DO - 10.1186/1756-8722-4-46 ID - Wei2011 ER -